Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze

被引:91
作者
Bailey, Kathleen R.
Pavlova, Maria N.
Rohde, Alex D.
Hohmann, John G.
Crawley, Jacqueline N.
机构
[1] Lab Behav Neurosci, Bethesda, MD USA
[2] Nara Inc, Seattle, WA 98104 USA
关键词
galanin; GalR2 null mutant; anxiogenic-like; mice; learning; memory; nociception; neuropeptide;
D O I
10.1016/j.pbb.2006.11.024
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The neuropeptide galanin has been implicated in anxiety-related behaviors, cognition, analgesia, and feeding in rodents. Neuromodulatory actions of galanin are mediated by three G-protein coupled receptors, GalR1, GalR2, and GalR3. The present study investigates the role of the GalR2 receptor by evaluating behavioral phenotypes of mice with a targeted mutation in the GalR2 gene. A three-tiered behavioral phenotyping approach first examined control measures of general health, body weight, neurological reflexes, sensory abilities land motor function. Mice were then assessed on several tests for cognitive and anxiety-like behaviors. GalR2 null mutants and heterozygotes were not significantly different from wildtype littermates on two cognitive tests previously shown to be sensitive to galanin manipulation: acquisition of the Morris water maze spatial task, and trace cued and contextual fear conditioning, an emotional learning and memory task. Two independent cohorts of GalR2 null mutant mice demonstrated an anxiogenic-like phenotype in the elevated plus-maze. No genotype differences were detected on several other measures of anxiety-like behavior. The discovery of an anxiogenic phenotype specific to the elevated plus-maze, similar to findings in GalR1 null mutants, highlights the potential therapeutic efficacy of targeting GalR1 and GalR2 receptors in treating anxiety disorders. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:8 / 20
页数:13
相关论文
共 84 条
[1]  
[Anonymous], 2000, What's Wrong with my Mouse?
[2]   Behavioral phenotyping of transgenic and knockout mice: Practical concerns and potential pitfalls [J].
Bailey, KR ;
Rustay, NR ;
Crawley, JN .
ILAR JOURNAL, 2006, 47 (02) :124-131
[3]   A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests [J].
Barr, Alasdair M. ;
Kinney, Jefferson W. ;
Hill, Matthew N. ;
Lu, Xiaoying ;
Biros, Shannon ;
Rebek, Julius, Jr. ;
Bartfai, Tamas .
NEUROSCIENCE LETTERS, 2006, 405 (1-2) :111-115
[4]   One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety? [J].
Barrera, G ;
Echevarria, DJ ;
Poulin, JF ;
Laforest, S ;
Drolet, G ;
Morilak, DA .
NEUROPEPTIDES, 2005, 39 (03) :289-292
[5]   Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests [J].
Bartfai, T ;
Lu, XY ;
Badie-Mahdavi, H ;
Barr, AM ;
Mazarati, A ;
Hua, XY ;
Yaksh, T ;
Haberhauer, G ;
Ceide, SC ;
Trembleau, L ;
Somogyi, L ;
Kröck, L ;
Rebek, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10470-10475
[6]   ANXIOLYTIC-LIKE ACTION OF CENTRALLY ADMINISTERED GALANIN [J].
BING, O ;
MOLLER, C ;
ENGEL, JA ;
SODERPALM, B ;
HEILIG, M .
NEUROSCIENCE LETTERS, 1993, 164 (1-2) :17-20
[7]   Cloning and expression of the human galanin receptor GalR2 [J].
Bloomquist, BT ;
Beauchamp, MR ;
Zhelnin, L ;
Brown, SE ;
Gore-Willse, AR ;
Gregor, P ;
Cornfield, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (02) :474-479
[8]   Habituation of activity in an open field:: A survey of inbred strains and F1 hybrids [J].
Bolivar, VJ ;
Caldarone, BJ ;
Reilly, AA ;
Flaherty, L .
BEHAVIOR GENETICS, 2000, 30 (04) :285-293
[9]   Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains [J].
Bouwknecht, JA ;
Paylor, R .
BEHAVIOURAL BRAIN RESEARCH, 2002, 136 (02) :489-501